Lanean...
Ribonuclease-Activated Cancer Prodrug
[Image: see text] Cancer chemotherapeutic agents often have a narrow therapeutic index that challenges the maintenance of a safe and effective dose. Consistent plasma concentrations of a drug can be obtained by using a timed-release prodrug strategy. We reasoned that a ribonucleoside 3′-phosphate co...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American
Chemical Society
2012
|
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353771/ https://ncbi.nlm.nih.gov/pubmed/22611478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml2002554 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|